{"id":967448,"date":"2026-05-27T09:08:36","date_gmt":"2026-05-27T13:08:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/"},"modified":"2026-05-27T09:08:36","modified_gmt":"2026-05-27T13:08:36","slug":"cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/","title":{"rendered":"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June"},"content":{"rendered":"<p>        <!--.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June<\/b><\/p>\n<p><b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity<\/i>.<\/b><\/p>\n<p>CHICAGO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998\">Cardio Diagnostics Holdings, Inc.<\/a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity.<\/p>\n<p>\nCardio Diagnostics\u2019 clinically validated blood tests, Epi+Gen CHD\u2122 and PrecisionCHD\u2122, combine epigenetics, genetics, and AI to help identify at-risk individuals before a life-threatening, costly cardiac event occurs. These tests go beyond proxy biomarkers for heart disease, such as cholesterol and blood pressure, to help improve plan member outcomes while equipping benefit leaders and organizations with an effective cost reduction strategy and helping brokers improve client retention. Paired with HeartRisk\u2122, the company\u2019s HIPAA-compliant real-time population insights platform, plan sponsors can benchmark cardiovascular risk across their workforce or membership, project both direct and indirect costs, and target benefits where they may have the greatest impact.<\/p>\n<p><b>Cardio Diagnostics will be exhibiting at the following conferences in June:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Greater Philadelphia Business Coalition on Health (GPBCH) Annual Conference <\/b>\u2014 June 4, 2026, Philadelphia, PA.\n<\/li>\n<li><b>Conner Strong &amp; Buckelew (CSB) Health &amp; Benefits Innovation Summit <\/b>\u2014<b \/>June 9, 2026, Philadelphia, PA.\n<\/li>\n<li><b>Midwest Employee Benefit Funds (MEBFC) Coalition, Inc. Annual Meeting <\/b>\u2014<b \/>June 12, 2026, Countryside, IL.\n<\/li>\n<li><b>Onsite Employee Health &amp; Wellness Centers Conference <\/b>\u2014 June 25-26, 2026,<b \/>Chicago, IL.\n<\/li>\n<\/ul>\n<p><b>Closing the Gap on a Preventable Crisis<\/b><\/p>\n<p>\nAccording to the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fworld-heart-federation.org%2Fwhat-we-do%2Fprevention%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=World+Heart+Federation&amp;index=2&amp;md5=08f101b35081f4f35958ab3e0cee346d\">World Heart Federation<\/a>, an estimated 80% of CVD can be prevented. Yet, CVD is one of the leading combined direct and indirect cost drivers of benefits plans. These rising costs can impact broker satisfaction while straining the budgets of employers and union funds.<\/p>\n<p>\nCardio Diagnostics\u2019 solutions can help to address this challenge. Epi+Gen CHD\u2122 can identify individuals at higher risk for a heart attack or sudden cardiac death in the next three years, even when traditional risk factors like cholesterol and blood pressure appear normal. PrecisionCHD\u2122 helps detect molecular signals associated with coronary heart disease before major symptoms or events may occur. When implemented, they work together to help individuals take preventive action while helping employers, unions, and brokers reduce spend and support a healthier, more productive workforce.<\/p>\n<p>\nMeesha Dogan, PhD, CEO and Co-Founder of Cardio Diagnostics, highlighted the company\u2019s unique position to partner with employers, brokers, and unions to tackle CVD. \u201cThe best benefits strategies do two things at once: bring spend down and keep individuals healthier. Cardiovascular disease presents an opportunity to do both. It\u2019s a top claims driver, and it\u2019s largely preventable when risk is identified early. Our precision tests and HeartRisk\u2122 platform give plan sponsors a clear, individualized path to lower direct and indirect costs while keeping the workforce healthier, longer.\u201d<\/p>\n<p><b>Connect with Cardio Diagnostics to Learn:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nHow epigenetic and genetic biomarkers can identify cardiovascular risk that traditional testing methods may miss.<\/p>\n<\/li>\n<li>\nWhy earlier detection of heart disease can translate into measurable claims reductions and fewer lost workdays.<\/p>\n<\/li>\n<li>\nHow our blood tests can be seamlessly integrated into an onsite clinic\u2019s workflow to help deliver more personalized care for plan members.<\/p>\n<\/li>\n<li>\nPractical models for integrating precision cardiovascular testing into existing wellness, chronic care, and benefits programs.<\/p>\n<\/li>\n<\/ul>\n<p>\nTo learn more about Cardio Diagnostics, meet with our team at any of the upcoming conferences.<\/p>\n<p><b>About Cardio Diagnostics<\/b><\/p>\n<p>\nCardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine (\u201cCore Technology\u201d) for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=https%3A%2F%2Fcdio.ai%2F&amp;index=3&amp;md5=5767953b687e3b4ee6dc6be044b64126\">https:\/\/cdio.ai\/<\/a>.<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nCertain statements and information included in this press release constitute \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases \u201cwill\u201d, \u201cwill likely result,\u201d \u201cexpected to,\u201d \u201cwill continue,\u201d \u201canticipated,\u201d \u201cestimate,\u201d \u201cprojected,\u201d \u201cintend,\u201d \u201cgoal,\u201d or similar expressions are intended to identify \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, dependence on results are discussed in the Current Report on Form 10-K for the period ended in December 31, 2025, under the heading \u201cRisk Factors\u201d in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company\u2019s financial performance and could cause the Company\u2019s actual results for future periods to differ materially from any opinions or statements expressed within this press release.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260527302873r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260527302873\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260527302873\/en\/<\/a><\/span><\/p>\n<p><b>Investors<br \/>\n<\/b><br \/>Investor Relations<br \/>\n<br \/>855-226-9991<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investors@cdio.ai\">investors@cdio.ai<br \/>\n<\/a><\/p>\n<p><b>Media &amp; Public Relations<br \/>\n<\/b><br \/>Public Relations<br \/>\n<br \/>855-226-9991<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:pr@cdio.ai\">pr@cdio.ai<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Illinois United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Cardiology Biotechnology Pharmaceutical General Health Health Medical Devices Health Technology Other Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260527302873\/en\/2815796\/3\/CARDIO_LOGO.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity. CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. Cardio Diagnostics\u2019 clinically validated blood tests, Epi+Gen CHD\u2122 and PrecisionCHD\u2122, combine epigenetics, genetics, and AI to help identify at-risk &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-967448","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity. CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. Cardio Diagnostics\u2019 clinically validated blood tests, Epi+Gen CHD\u2122 and PrecisionCHD\u2122, combine epigenetics, genetics, and AI to help identify at-risk &hellip; Continue reading &quot;Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-27T13:08:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260527302873r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June\",\"datePublished\":\"2026-05-27T13:08:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/\"},\"wordCount\":927,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260527302873r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/\",\"name\":\"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260527302873r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-05-27T13:08:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260527302873r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260527302873r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/","og_locale":"en_US","og_type":"article","og_title":"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June - Market Newsdesk","og_description":"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity. CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. Cardio Diagnostics\u2019 clinically validated blood tests, Epi+Gen CHD\u2122 and PrecisionCHD\u2122, combine epigenetics, genetics, and AI to help identify at-risk &hellip; Continue reading \"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-27T13:08:36+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260527302873r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June","datePublished":"2026-05-27T13:08:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/"},"wordCount":927,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260527302873r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/","name":"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260527302873r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-05-27T13:08:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260527302873r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260527302873r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-holdings-inc-to-showcase-precision-cardiovascular-solutions-at-four-national-benefits-conferences-in-june\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967448","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=967448"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967448\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=967448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=967448"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=967448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}